Rapid high-throughput profiling and quantitation of sialic acids in biotherapeutics
8 Jul 2020This poster presents a new high-throughput workflow based on a 96-well plate format for the release, labeling, and analysis of sialic acids from therapeutic glycoproteins using rituximab, etanercept, and NISTmAb as examples. Sialic acid residues are released then labeled with 1,2-diamino-4,5methylenedioxybenzene (DMB) in a two-step procedure.
Related Products
Request Quote for All Products
Agilent 1290 Infinity II LC System
Agilent TechnologiesThe 1290 Infinity II LC System is an ultra-high performance LC that has market-leading sample capacity and is designed for the lowest dispersion for the most challenging ultra-HPLC experiments. The 1290 Infinity II LC system is designed to be both a HPLC and high-end UHPLC system in a single flow path, giving you robust and excellent performance no matter what application you are running while seamlessly integrating into your existing laboratory environment.
6545XT AdvanceBio LC/Q-TOF
Agilent TechnologiesThe Agilent 6545XT AdvanceBio LC/Q-TOF system is designed to handle multiple workflows in biopharmaceutical characterization. When you need to access the most detailed information at the intact protein level, automatically confirm protein sequence at the peptide level, and confidently understand post-translational modifications, the 6545XT AdvanceBio Q-TOF delivers results you can trust.